A Study to Investigate the Pharmacokinetic Interactions Between Simeprevir and Ledipasvir in a Treatment Regimen Consisting of Simeprevir, Sofosbuvir, and Ledipasvir in Treatment-naive Participants With Chronic Hepatitis C Virus Genotype 1 Infection
Clinical trial NCT02421211 · COMPLETED
Trial details
- NCT number
- NCT02421211
- Sponsor
- Janssen Sciences Ireland UC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-05-19
- Primary completion
- 2015-11-10
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.